US Patent Issued to I.D.BIO. on March 24 for "Recombinant influenza viruses comprising truncated NS1 fusion proteins" (South Korean Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,708, issued on March 24, was assigned to I.D.BIO. (Cheongju-si, South Korea).

"Recombinant influenza viruses comprising truncated NS1 fusion proteins" was invented by Young-Jae Si (Cheongju-si, South Korea), Hyuk-Il Kwon (Cheongju-si, South Korea) and Yeo-Jeong Choi (Cheongju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a novel recombinant influenza virus, in which an interferon-beta gene, which is a foreign gene associated with an antiviral action, is introduced to an NS1 gene which is an influenza virus gene that is expressed first in the host to suppress the host immune system when infected wit...